Pharnext

Company Description

---

Our company

Pharnext is an advanced clinical-stage biopharmaceutical company developing novel therapeutics for neurodegenerative diseases with high unmet medical needs.

Our drug Candidates

Two drug candidates are currently in clinical development: PXT3003 for the treatment of Charcot-Marie-Tooth disease type 1A and PXT864 for Alzheimer’s disease. Both of our lead assets originated from the Pleotherapy R&D approach.

Year founded

---

2007

Served area

---

Worldwide

Headcount

---

44

Headquarters

---

46 Rue Saint Lazare, 75009 Paris – France